The biotech firm Moderna Therapeutics announced that the first eight participants in the Phase 1 of its COVID-19 vaccine trial developed some antibodies after a single dose. Moderna is now expected to start a second round of clinical trials as soon as next month. Dr. David Agus joined "CBS This Morning" to explain the development and the latest in the race for a vaccine.
